Detalles de la búsqueda
1.
Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study.
BMC Nephrol
; 25(1): 69, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38408970
2.
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
BMC Nephrol
; 24(1): 12, 2023 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642717
3.
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
BMC Nephrol
; 24(1): 22, 2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703103
4.
No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.
Microbiol Spectr
; : e0034224, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38864641
5.
Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study.
Antimicrob Resist Infect Control
; 11(1): 119, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36175948
6.
Splenic mass of uncertain etiology in a 15-year-old male patient: a case report.
Acute Med Surg
; 7(1): e464, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31988776
Resultados
1 -
6
de 6
1
Próxima >
>>